# DESyne in Routine Clinical Practice

> **NCT02039713** · — · TERMINATED · sponsor: **Seung-Jung Park** · enrollment: 342 (actual)

## Conditions studied

- Angioplasty, Transluminal, Percutaneous Coronary
- Coronary Artery Disease

## Interventions

- **DEVICE:** DeSyne drug eluting stent group

## Key facts

- **NCT ID:** NCT02039713
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2021-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039713, "DESyne in Routine Clinical Practice". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02039713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*